Drug Recall for Baxter Sodium Chloride 2.25g/250mL

HPS Pharmacies wish to give notice that Baxter, in consultation with the Therapeutic Goods Administration (TGA), has initiated a drug recall for Sodium Chloride bags as follows:

Baxter 0.9% Sodium Chloride Injection BP Bag
Sodium Chloride 2.25g/250mL
ARTG 48517

This drug recall was initiated following the identification of a weak seal on the side of the intravenous solution bag, which may result in leakage when the bag is squeezed. This presents a risk of microbial contamination, delays in therapy, or under-delivery of therapy. Baxter has not received any reports of adverse events associated with this issue.

The batches affected by this recall are:

• X83L8
• X83P7
• X83P8
• X83L9
• X83S9
• X84F1

Please inspect your stock and quarantine any defect stock. If HPS Pharmacies provides this product on imprest to your facility, an HPS representative will inspect all stock stored in the designated imprest areas at the earliest opportunity. All affected products will be quarantined for return to the supplier, and HPS Pharmacies will arrange for replacement stock as soon as possible. An HPS Pharmacies staff member will contact senior medical and nursing staff if there is an immediate impact to your facility.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Baxter on 1800 229 837 or your pharmacist at HPS Pharmacies.

Download PDF